Filing Details

Accession Number:
0001104659-20-123596
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-10 16:19:06
Reporting Period:
2020-11-09
Accepted Time:
2020-11-10 16:19:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356576 Supernus Pharmaceuticals Inc. SUPN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219844 S Gregory Patrick C/O Supernus Pharmaceuticals, Inc.
9715 Key West Avenue
Rockville MD 20850
Sr. Vp Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-09 5,000 $12.98 49,463 No 4 M Direct
Common Stock Disposition 2020-11-09 5,000 $25.00 44,463 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2020-11-09 5,000 $0.00 5,000 $12.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2026-03-01 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted September 15, 2020.
  2. The option vests in four equal annual installments beginning on March 1, 2017.